Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 123.11
+5.79 (4.94%)
At close: Jan 23, 2026
Bafna Pharmaceuticals Company Description
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India.
It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries.
Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.
Bafna Pharmaceuticals Limited
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 406 |
| CEO | Bansilal Mahaveer Bafna |
Contact Details
Address: Bafna Towers Chennai, Tamil Nadu 600001 India | |
| Phone | 91 44 2526 7517 |
| Website | bafnapharma.com |
Stock Details
| Ticker Symbol | BAFNAPH |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE878I01022 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bansilal Mahaveer Chand Bafna | Chief Executive Officer |
| Melagiri Sridhar | Chief Financial Officer |
| A. Mohanachandran | Company Secretary and Compliance Officer |
| Vinayak Dinesh Dendukuri | Whole-Time Director of Quality and Whole-Time Director |
| Shanmugam Hemalatha | Whole-Time Director |